121 related articles for article (PubMed ID: 38193169)
1. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
[TBL] [Abstract][Full Text] [Related]
2. Idylla
Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the Idylla
Petiteau C; Robinet-Zimmermann G; Riot A; Dorbeau M; Richard N; Blanc-Fournier C; Bibeau F; Deshayes S; Bergot E; Gervais R; Levallet G
Curr Oncol; 2021 Nov; 28(6):4432-4445. PubMed ID: 34898548
[TBL] [Abstract][Full Text] [Related]
4. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
[TBL] [Abstract][Full Text] [Related]
5. Reduced sensitivity for
Lee E; Jones V; Topkas E; Harraway J
J Clin Pathol; 2021 Jan; 74(1):43-47. PubMed ID: 32467321
[TBL] [Abstract][Full Text] [Related]
6. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
[TBL] [Abstract][Full Text] [Related]
7. Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Momeni-Boroujeni A; Salazar P; Zheng T; Mensah N; Rijo I; Dogan S; Yao J; Moung C; Vanderbilt C; Benhamida J; Chang J; Travis W; Rekhtman N; Ladanyi M; Nafa K; Arcila ME
J Mol Diagn; 2021 Mar; 23(3):310-322. PubMed ID: 33346146
[TBL] [Abstract][Full Text] [Related]
8. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
[TBL] [Abstract][Full Text] [Related]
9. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract][Full Text] [Related]
10. [EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
Chevalier LM; Billaud A; Passot C; Renoult A; Bigot F; Verrièle V; Morel A
Ann Pathol; 2020 Sep; 40(5):389-400. PubMed ID: 32081549
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.
Grant J; Stanley A; Balbi K; Gerrard G; Bennett P
J Clin Pathol; 2022 Apr; 75(4):241-249. PubMed ID: 33514586
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a fast and fully automated platform to diagnose
Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
[TBL] [Abstract][Full Text] [Related]
13. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Idylla system to detect the EGFR
Bocciarelli C; Cohen J; Pelletier R; Tran Van Nhieu J; Derman J; Favre L; Bourgogne A; Monnet I; Chouaid C; Pujals A
Pathol Res Pract; 2020 Jan; 216(1):152773. PubMed ID: 31836323
[TBL] [Abstract][Full Text] [Related]
15. Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples.
Hawkins P; Stevenson T; Powari M
Am J Clin Pathol; 2021 Sep; 156(4):653-660. PubMed ID: 33877290
[TBL] [Abstract][Full Text] [Related]
16. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
Joshi P; Gogte P; Pai T; Gurav M; Dhanawade D; Karnik N; Deshpande G; Kaushal R; Shetty O
Int J Exp Pathol; 2024 Jun; 105(3):90-99. PubMed ID: 38717047
[TBL] [Abstract][Full Text] [Related]
17. Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing.
Nkosi D; Casler VL; Syposs CR; Oltvai ZN
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627184
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
[TBL] [Abstract][Full Text] [Related]
19. Mutation Spectrum of
Mao L; Zhao W; Li X; Zhang S; Zhou C; Zhou D; Ou X; Xu Y; Tang Y; Ou X; Hu C; Ding X; Luo P; Yu S
Pathol Oncol Res; 2021; 27():602726. PubMed ID: 34257561
[TBL] [Abstract][Full Text] [Related]
20. Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huang H; Springborn S; Haug K; Bartow K; Samra H; Menon S; Mackinnon AC
J Mol Diagn; 2019 Sep; 21(5):862-872. PubMed ID: 31443844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
